Skip to content

The effect of myopia control and influence of visual quality in children treated with orthokeratology of aspherical base curve design

The effect of myopia control and influence of visual quality in children treated with orthokeratology of aspherical base curve design

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040990
Enrollment
Unknown
Registered
2020-12-16
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Group 1:Aspherical base curve designed orthokeratology
Group 2:Spherical base curve designed orthokeratology

Sponsors

West China hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Age between 8 and 12 years old; (2) The best corrected ETDRS visual acuity in a single eye is >= 20/25; (3) Diopters of sphere between -0.75~-4.00D; (4) Corneal astigmatism <= 1.50D, axis at 180±30, subjective refraction astigmatism <= 1.00D; (5) Anisometropia <= 1.00D; (6) Except for conventional glasses, no other methods of myopia control, no history of wearing contact lenses; (7) At the beginning of the trial, follow-up visits to West China Hospital according to the trial design arrangement until the lens wearing time reaches 12 months; (8) Sleep more than 8 hours per night, wear at least 6 nights per week; (9) The refractive medium of the examined eye is clear; (10) The examined eye has no nystagmus and has good fixation ability.

Exclusion criteria

Exclusion criteria: (1) Narrow anterior chamber or intraocular pressure> 21mmHg; (2) Suffering from keratitis, keratoconus, glaucoma, strabismus and amblyopia; (3) Suffering from mental illness; (4) The history of wearing contact lenses; (5) Cardiopulmonary insufficiency; (6) Severe eye discomfort; (7) Accommodative insufficiency; (8) Poor compliance, and the researcher thinks it is inappropriate to continue participating in this trial; (9) Subjects require to quit.

Design outcomes

Primary

MeasureTime frame
axial length;corneal endothelial;tear break-up time;visual acuity;relative peripheral refraction;subfoveal choroidal thickness;aberration;corneal thickness;ocular surface disease index,;tear meniscus height;Schirmer?test;subjective refraction;objective refraction;

Countries

China

Contacts

Public ContactWei Ma

West China Hospital, Sichuan University

18038862@qq.com+86 18113151618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026